Postoperative Chemotherapy with Cisplatin and 5-Fluorouracil in Cancer of the Oral Cavity and the Oropharynx - Long-Term Results

REFERENCES

• Weaver A, Fleming S, Vandenberg H, et al. Cis-plat-inum and 5-fluorouracil as initial therapy in advanced epidermold cancers of the head and neck. Head Neck Surg. 1982; 4: 370–373.
   PubMedGoogle Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000; 355: 949–955.
   Google Scholar
• Posner MR, Colevas AD, Tishler RB. The role of induc-tion chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol 2000; 27(Suppl 8): 13–24.
   PubMedGoogle Scholar
• Skipper HE, Schabel FM, Wilcox WS. Experimental evaluation of potential anticancer agents: XII. On the criteria and kinetics associated with „curability” of experimental leukemia. Cancer Chemother Rep. 1964; 35: 1–111.
   PubMedGoogle Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–655.
   PubMed Web of Science ®Google Scholar
• Hermanek P, Sobin LH. UICC: TNM Classification of Malignant Tumours. Berlin: Springer, 1987.
   Google Scholar
• Platz H2. Fries R, Hudec M. Einführung in die „Prospektive DOSAK-Studie über Plattenepithelkarzinome der Lippen, der Mundhöhle und des Oropharynx”. Dtsch Z Mund Kiefer GesichtsChir 1988; 12: 293-302.
   Google Scholar
• Howaldt HP. Data collection-the DOSAK experience. In: Booth PW, Schendel SA, Hausamen JE, eds. Maxillofacial Surgery. Edinburgh: Churchill Livingstone, 1999: 815–821.
   Google Scholar
• Bier J. Definitionen aim radikalchirurgischen Vqrgehen bei Plattenepithelkarzinomen der Mundhöhle. Deutsch-Osterre-ichisch-Schweizerischer Arbeitskreis ftir Tumoren im Kiefer-und Gesichtsbereich (DOSAK). Dtsch Z Mund-Kiefer-GesichtsChir 1982; 6: 369–372.
   Google Scholar
• Hausamen J-E, Schliephake H. Principles of surgical management. In: Booth PW, Schendel SA, Hausamen J-E, eds. Maxillofacial Surgery. Edinburgh: Churchill Livingstone, 1999: 361–372.
   Google Scholar
• Platz H, Fries R, Hudec M. Retrospektive DOSAK-Studie über Karzinome der Mundhöhle. Therapieabhängiger Prognoseindex TPI. Dtsch Z Mund Kiefer GesichtsChir 1983; 7: 287–296.
   Google Scholar
• Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
   Google Scholar
• Bortz J, Lienert GA, Boehnke K. Verteilungsfreie Methoden in der Biostatistik. Berlin: Springer, 1990.
   Google Scholar
• Medina JE. A rational classification of neck dissections. Otolaryngol Head Neck Surg 1989; 100: 169–176.
   PubMed Web of Science ®Google Scholar
• Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissections termi-nology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology [see comments]. Arch Otolaryngol Head Neck Surg. 1991; 117: 601–605.
   PubMedGoogle Scholar
• Bier J, Schlums D, Metelmann H, Howaldt HP, Pitz H. A comparison of radical and conservative neck dissection. Int J Oral Maxillofac Surg 1993; 22: 102–107.
   PubMed Web of Science ®Google Scholar
• Andersen PE, Shah JP, Cambronero E, Spiro RH. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg 1994; 168: 499–502.
   PubMed Web of Science ®Google Scholar
• Taylor SG 4th, Applebaum E, Showel JL, et al. A ran-domized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 1985; 3: 672–679.
   Google Scholar
• Ervin TJ, Clark JR, Weichselbaum RR, et al. An analy-sis of induction and adjuvant chemotherapy in the multidisci-plinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987; 5: 10–20.
   PubMed Web of Science ®Google Scholar
• Grau JJ, Estape J, Blanch JL, et al. Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV. Eur J Cancer B Oral Oncol 1996; 32B: 238–241.
   PubMed Web of Science ®Google Scholar
• Athanasiadis I, Taylor S 4th, Vokes EE, et al. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center. Cancer 1997; 79: 588–594.
   Google Scholar
• Forastiere AA, Baker SR, Wheeler R, Medvec BR. Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. J Clin Oncol 1987; 5: 1601–1606.
   PubMed Web of Science ®Google Scholar
• Johnson JT, Myers EN, Schramm VL Jr, et al. Adjuvant chemotherapy for high-risk squamous-cell carcinoma of the head and neck. J Clin Oncol 1987; 5: 456–458.
   PubMed Web of Science ®Google Scholar
• Rentschler RE, Wilbur DW, Petti GH, et al. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas-a prospective, ran-domized study. J Clin Oncol 1987; 5: 278–285.
   PubMed Web of Science ®Google Scholar
• Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992; 23: 705–713.
   PubMed Web of Science ®Google Scholar
• Amrein PC, Colecchi CH, Finkelstein DM, Fabian RL. Adjuvant chemotherapy in advanced head and neck cancer. Oncologist 1997; 2: 135–141.
   PubMedGoogle Scholar
• Rao RS, Parikh DM, Parikh HK, Bhansali MB, Deshmane VH, Fakih AR. Perioperative chemotherapy in patients with oral cancer. Am J Surg 1994; 168: 262–267.
   PubMed Web of Science ®Google Scholar
• Szpirglas H, Chastang C, Bertrand JC. Adjuvant treat-ment of tongue and floor of the mouth cancers. Recent Results Cancer Res 1978; 68: 309–317.
   PubMedGoogle Scholar
• Jacobs C, Makuch R. Efficacy of adjuvant chemothera-py for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990; 8: 838–847.
   PubMed Web of Science ®Google Scholar
• Basu S, Khanra M, Dash B, Majumdar J, Biswas J, Chaudhuri P. The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer. Med Oncol 1999; 16: 199–203.
   PubMed Web of Science ®Google Scholar
• Lam P, Yuen AP, Ho CM, Ho WK, Wei WI. Prospective randomized study of post-operative chemotherapy with levamisole and UFT for head and neck carcinoma. Eur J Surg Oncol 2001; 27: 750–753.
   PubMed Web of Science ®Google Scholar
• Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and dox-orubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988; 6: 1401-1410.
   Google Scholar
• Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779–787.
   PubMed Web of Science ®Google Scholar
• Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83–91.
   PubMed Web of Science ®Google Scholar
• Licitra L, Grandi C, Guzzo M, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 2003; 21: 327–333.
   PubMed Web of Science ®Google Scholar